Danaher Corporation (DHR) has been identified as a significant pick among several billionaire investors such as Ken Fisher, Charles Akre, and John Neff, potentially offering massive upside. However, the corporation faced challenges in China, causing investor Jim Cramer to call for the CEO to step up or step aside. Various banks and investment firms have altered their holdings in DHR, with prominent activity noted.
Sales performance and
bioprocessing growth were highlights of
Q1 2025 Earnings despite certain metrics falling below estimates. Despite the mixed performance, DHR beat earnings estimates, leading its stock to trade up. Nevertheless, the Q1 result was a mix of strengths and stagnation, revealing
revenue beat but an
EPS miss. Adjustments to target prices and ratings have been made due to the oscillating performance, with some firms walking the bearish path. There's keen interest in their next move considering near five-year lows and slipping metrics over a three-year earnings period. Nevertheless, DHR remains a fascinating stock with analysts positively looking at its long-term prospects given decent financials and low valuations.
Danaher Corporation DHR News Analytics from Sat, 08 Feb 2025 08:00:00 GMT to Sat, 03 May 2025 15:14:23 GMT -
Rating 4
- Innovation 2
- Information 8
- Rumor 4
